Nov. 6, 2023, 11 a.m. | Nacha Cattan, Kanoko Matsuyama

Bloomberg Technology bloomberg.com

A medicine’s effectiveness can vary across racial and ethnic groups, and drugmakers such as Johnson & Johnson are hoping to expand participation beyond the overwhelmingly White populations in current testing.

beyond big big pharma clinical clinical trials current diversity medicine pharma testing

AI Research Scientist

@ Vara | Berlin, Germany and Remote

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Data Science Analyst

@ Mayo Clinic | AZ, United States

Sr. Data Scientist (Network Engineering)

@ SpaceX | Redmond, WA